Results 121 to 130 of about 7,770 (204)

Health literacy and biosimilar acceptance in people with multiple sclerosis: a cross-sectional study. [PDF]

BMC Nurs
Pastore F, Cicolini G, Forastefano B, Domenicone E, De Summa S, Comparcini D, Simonetti V.   +6 more
europepmc   +1 more source

Pulmonary Hypertension Following the Use of Trastuzumab Biosimilars. [PDF]

Case Rep Pulmonol
Ojo T, Cablay K, Emara N, Meyer A.
europepmc   +1 more source

Assessing Nurses' Knowledge and Attitudes Towards Biosimilars: Results from a National Survey. [PDF]

Healthcare (Basel)
Domínguez-Fernández S, Montenegro-Méndez S, González-Rodríguez M, Cano-Sanz N, Duro-Martínez AM, Bella-Castillo P, Fontán-Vinagre G, Guerrero-Menéndez R.   +7 more
europepmc   +1 more source

Shaping the future of retinal care in India: Anti-VEGF therapy now and beyond. [PDF]

Indian J Ophthalmol
Karpe A, Narula R, Shroff D, Roy A.
europepmc   +1 more source

Impact on hospitals of price reductions for physician-administered biologics. [PDF]

Health Aff Sch
Robinson JC, Thomson M, Kosorukov AD, Whaley CM.   +3 more
europepmc   +1 more source

Clinical evidence and implementation guidance for biosimilar switching in ankylosing spondylitis. [PDF]

Front Pharmacol
Cai L, Chen X, Fang Y, Li L, Liu T, Gan Z, Zuo Z.   +6 more
europepmc   +1 more source

Biosimilars in pemphigus vulgaris

Indian Journal of Dermatology, 2014
Sharmila Patil, Nidhi Sharma, Kiran Godse, Nitin Nadkarni   +3 more
openaire   +3 more sources

Peep into anti-vascular endothelial growth factor. [PDF]

Indian J Ophthalmol
Verma L, Singh S, Ramachandran O.
europepmc   +1 more source

Navigating the Transition: A Scoping Review of System-Level Factors in Biosimilar Integration for Immune-Mediated Inflammatory Diseases. [PDF]

BioDrugs
Kumar S, Dalbeth N, Gasteiger C.
europepmc   +1 more source

Anti-VEGF Therapies in Retinal Disorders: Current Landscape and Future Directions. [PDF]

Clin Ophthalmol
Sheth JU.
europepmc   +1 more source